Withdrawal of two generic clopidogrel products in Saudi Arabia for non-bio-equivalence

To the Editor: Clopidogrel, a P2Y12 platelet inhibitor, is indicated for the treatment of cardiovascular and cerebrovascular events.1-3 In February 2018, the Saudi Food and
Source: Annals of Saudi Medicine - Category: General Medicine Tags: ISSUE 3 Source Type: research